Prucalopride Treatment for Refractory Gastro-esophageal Reflux Disease
NCT03676374
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
GERD
Interventions
DRUG:
Prucalopride
DRUG:
Placebo Oral Tablet
Sponsor
Universitaire Ziekenhuizen KU Leuven